Back

dr. ing. E. (Esmé) Waanders

dr. ing. E. (Esmé) Waanders

Researcher/Postdoc

Show full profile

Research Output (37)

Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion

Venn N C, van der Velden V H J, de Bie M, Waanders E, Giles J E, Law T, Kuiper R P, de Haas V, Mullighan C G, Haber M, Marshall G M, Md Norris, van Dongen J J M, Sutton R Jun 2012, In: Leukemia. 26 , p. 1414-6 3 p.

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

Waanders E, van der Velden V H J, van der Schoot C E, van Leeuwen F N, van Reijmersdal S V, de Haas V, Veerman A J, van Kessel A Geurts, Hoogerbrugge P M, Kuiper R., van Dongen J J M Feb 2011, In: Leukemia. 25 , p. 254-8 5 p.

TET2 mutations in childhood leukemia

Langemeijer S M C, Jansen J H, Hooijer J, van Hoogen P, Stevens-Linders E, Massop M, Waanders E, van Reijmersdal S V, Stevens-Kroef M J P L, Zwaan C M, van den Heuvel-Eibrink M M, Sonneveld E, Hoogerbrugge P M, van Kessel A Geurts, Kuiper R P Jan 2011, In: Leukemia. 25 , p. 189-92 4 p.

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63

Waanders E, Venselaar H, te Morsche R H M, de Koning D B, Kamath P S, Torres V E, Somlo S, Drenth J P H Jul 2010, In: Clinical Genetics. 78 , p. 47-56 10 p.

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL

Kuiper R P, Waanders E., van der Velden V H J, van Reijmersdal S V, Venkatachalam R, Scheijen B, Sonneveld E, van Dongen J J M, Veerman A J P, van Leeuwen F N, van Kessel A Geurts, Hoogerbrugge P.M. Jul 2010, In: Leukemia. 24 , p. 1258-64 7 p.

BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia

van Galen Joost C, Kuiper Roland P, van Emst Liesbeth, Levers Marloes, Tijchon Esther, Scheijen Blanca, Waanders Esmé, van Reijmersdal Simon V, Gilissen Christian, van Kessel Ad Geurts, Hoogerbrugge Peter M, van Leeuwen Frank N 10 Jun 2010, In: Blood. 115 , p. 4810-9 10 p.

Comment on:How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?

Waanders E, van Keimpema L, Drenth J P H Mar 2010, In: Digestive and liver disease. 42 , p. 234-5 2 p.

Congenital disorders of glycosylation in hepatology:the example of polycystic liver disease

Janssen Manoe J, Waanders Esmé, Woudenberg Jannes, Lefeber Dirk J, Drenth Joost P H Mar 2010, In: Journal of Hepatology. 52 , p. 432-40 9 p.

Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease

Waanders Esmé, van Keimpema Loes, Brouwer Johannes T, van Oijen Martijn G H, Aerts Raymond, Sweep Fred C G J, Nevens Frederik, Drenth Joost P H Oct 2009, In: Liver International. 29 , p. 1389-95 7 p.

Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease

Waanders Esmé, Van Krieken J Han J M, Lameris Anke L L, Drenth Joost P H Nov 2008, In: Modern Pathology. 21 , p. 1293-302 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not